138 related articles for article (PubMed ID: 36012038)
1. Endometrial Cancer in Aspect of Forkhead Box Protein Contribution.
Adamczyk-Gruszka O; Horecka-Lewitowicz A; Gruszka J; Wawszczak-Kasza M; Strzelecka A; Lewitowicz P
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36012038
[TBL] [Abstract][Full Text] [Related]
2. Forkhead-box A1 suppresses the progression of endometrial cancer via crosstalk with estrogen receptor α.
Wang J; Bao W; Qiu M; Liao Y; Che Q; Yang T; He X; Qiu H; Wan X
Oncol Rep; 2014 Mar; 31(3):1225-34. PubMed ID: 24452315
[TBL] [Abstract][Full Text] [Related]
3. Targeted gene sequencing of Lynch syndrome-related and sporadic endometrial carcinomas.
Libera L; Craparotta I; Sahnane N; Chiaravalli AM; Mannarino L; Cerutti R; Riva C; Marchini S; Furlan D
Hum Pathol; 2018 Nov; 81():235-244. PubMed ID: 30420047
[TBL] [Abstract][Full Text] [Related]
4. Clear cell carcinoma of the endometrium: an immunohistochemical and molecular analysis of 45 cases.
Zannoni GF; Santoro A; Angelico G; Spadola S; Arciuolo D; Valente M; Inzani F; Pettinato A; Vatrano S; Fanfani F; Scambia G; Fraggetta F
Hum Pathol; 2019 Oct; 92():10-17. PubMed ID: 31269413
[TBL] [Abstract][Full Text] [Related]
5. Strong correlation between molecular changes in endometrial carcinomas and concomitant hyperplasia.
Zauber P; Denehy TR; Taylor RR; Ongcapin EH; Marotta S; Sabbath-Solitare M
Int J Gynecol Cancer; 2015 Jun; 25(5):863-8. PubMed ID: 25768080
[TBL] [Abstract][Full Text] [Related]
6. Pathology of Endometrial Carcinoma.
Lax SF
Adv Exp Med Biol; 2017; 943():75-96. PubMed ID: 27910065
[TBL] [Abstract][Full Text] [Related]
7. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J
Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
[TBL] [Abstract][Full Text] [Related]
8. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability.
Haruma T; Nagasaka T; Nakamura K; Haraga J; Nyuya A; Nishida T; Goel A; Masuyama H; Hiramatsu Y
PLoS One; 2018; 13(4):e0195655. PubMed ID: 29659608
[TBL] [Abstract][Full Text] [Related]
10. High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.
Garcia-Dios DA; Lambrechts D; Coenegrachts L; Vandenput I; Capoen A; Webb PM; Ferguson K; ; Akslen LA; Claes B; Vergote I; Moerman P; Van Robays J; Marcickiewicz J; Salvesen HB; Spurdle AB; Amant F
Gynecol Oncol; 2013 Feb; 128(2):327-34. PubMed ID: 23219661
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer.
Takayama K; Suzuki T; Tsutsumi S; Fujimura T; Takahashi S; Homma Y; Urano T; Aburatani H; Inoue S
Mol Endocrinol; 2014 Dec; 28(12):2012-24. PubMed ID: 25329375
[TBL] [Abstract][Full Text] [Related]
12. Forkhead box transcription factor, forkhead box A1, shows negative association with lymph node status in endometrial cancer, and represses cell proliferation and migration of endometrial cancer cells.
Abe Y; Ijichi N; Ikeda K; Kayano H; Horie-Inoue K; Takeda S; Inoue S
Cancer Sci; 2012 Apr; 103(4):806-12. PubMed ID: 22313737
[TBL] [Abstract][Full Text] [Related]
13. The Role of KRAS in Endometrial Cancer: A Mini-Review.
Sideris M; Emin EI; Abdullah Z; Hanrahan J; Stefatou KM; Sevas V; Emin E; Hollingworth T; Odejinmi F; Papagrigoriadis S; Vimplis S; Willmott F
Anticancer Res; 2019 Feb; 39(2):533-539. PubMed ID: 30711927
[TBL] [Abstract][Full Text] [Related]
14. Forkhead-box A1 induces cell senescence in endometrial cancer by regulating p16INK4a.
Wang J; Bian Y; Liao Y; Xia Y; Wan X
Oncol Rep; 2016 Aug; 36(2):795-802. PubMed ID: 27349269
[TBL] [Abstract][Full Text] [Related]
15. The expression and correlation between the transcription factor FOXP1 and estrogen receptors in epithelial ovarian cancer.
Hu Z; Zhu L; Tan M; Cai M; Deng L; Yu G; Liu D; Liu J; Lin B
Biochimie; 2015 Feb; 109():42-8. PubMed ID: 25500588
[TBL] [Abstract][Full Text] [Related]
16. The Roles of TP53 and FGFR2 in Progress Made Treating Endometrial Cancer.
Adamczyk-Gruszka O; Horecka-Lewitowicz A; Strzelecka A; Wawszczak-Kasza M; Gruszka J; Lewitowicz P
Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885641
[TBL] [Abstract][Full Text] [Related]
17. Detection of somatic mutations in peritoneal lavages and plasma of endometrial cancer patients: A proof-of-concept study.
Mayo-de-Las-Casas C; Velasco A; Sanchez D; Martínez-Bueno A; Garzón-Ibáñez M; Gatius S; Ruiz-Miró M; Gonzalez-Tallada X; Llordella I; Tresserra F; Rodríguez S; Aldeguer E; Roman-Canal B; Bertran-Alamillo J; García-Peláez B; Rosell R; Molina-Vila MA; Matias-Guiu X
Int J Cancer; 2020 Jul; 147(1):277-284. PubMed ID: 31953839
[TBL] [Abstract][Full Text] [Related]
18. FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer.
Qiu M; Bao W; Wang J; Yang T; He X; Liao Y; Wan X
BMC Cancer; 2014 Feb; 14():78. PubMed ID: 24512546
[TBL] [Abstract][Full Text] [Related]
19. FOXP1: a potential therapeutic target in cancer.
Koon HB; Ippolito GC; Banham AH; Tucker PW
Expert Opin Ther Targets; 2007 Jul; 11(7):955-65. PubMed ID: 17614763
[TBL] [Abstract][Full Text] [Related]
20. Analysis of a correlation between the BRAF V600E mutation and abnormal DNA mismatch repair in patients with sporadic endometrial cancer.
Kawaguchi M; Yanokura M; Banno K; Kobayashi Y; Kuwabara Y; Kobayashi M; Nomura H; Hirasawa A; Susumu N; Aoki D
Int J Oncol; 2009 Jun; 34(6):1541-7. PubMed ID: 19424571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]